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INTRODUCTION
Coronary artery aneurysms (CAN) are defined as morethan 50% dilatation of coronary arteries compared toreference vessels diameter,1 with incidence of 0.35 to6.0%.2,3 Previously, CAN had been reported with baremetal stents (BMS) secondary to stretch, stent fractureand dissection.2 Recently, increasing number of casesreport CAN after drug-eluting stent (DES) implantation.4,5
To the best of the authors' knowledge, the first casepresented from Pakistan of a left anterior descending(LAD) CAN after DES implantation treated successfullywith stenting.
CASE REPORT
An 85-year lady with a history of percutaneousintervention (PCI) to left anterior descending LAD withCypherTM stent (DES) in 2007, presented to theEmergency Department of The Aga Khan UniversityHospital with increasing restlessness and cough. Shehad a pulse of 110 beats/minute, respiratory rate of 40breaths/minute and blood pressure of 90/60 mmHg. Shehad bibasilar crepitations on auscultation and troponin-Iof 10.5 ng/ml. Her electrocardiogram (ECG) showed oldleft bundle branch block. Transthoracic echocardiogramshowed an estimated ejection fraction of 25-30%with akinetic apex, septum, mid anterior segments along
with mild-moderate aortic stenosis and moderate mitralregurgitation.
She underwent a left heart catheterisation via right femoralartery 6F sheath (Cordis®). Left coronary system wasvisualised using JL4 6F` catheter showing short left mainvessel bifurcating into LAD and left circumflex vessels(LCx). LAD had tight in-stent re-stenosis (ISR) in theproximal part of previous stent (Cypher 2.5x23 mm),followed by CAN (Figures 1A and 1B). LCx had mildplaquing. Right coronary artery was engaged using JR46F` diagnostic catheter, showing mild plaquing.
The left main artery was engaged with VL3 (Cordis®)guiding catheter and LAD wired with BMW (Abbott®)
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ABSTRACTThe ability of drug-eluting stent (DES) to inhibit intimal proliferation has resulted in a massive increase in their usage overthe years. However, it is known that the application of DES can alter the normal cascade of vascular healing, resulting indelayed endothelialisation with risk of vascular complications. Coronary artery aneurysms (CAN) are defined as more than50% dilatation of the coronary artery compared to the reference vessel diameter with the reported incidence afterpercutaneous intervention (PCI) being only around 0.35 to 6.0%. Previously, CAN had been reported with the use of baremetal stent secondary to stretch, stent fracture and dissection. However, recently, increasing number of cases have beenreported describing CAN after DES implantation. To the best of the authors' knowledge, they present the first case fromPakistan of a left anterior descending coronary artery aneurysm after DES implantation treated successfully with stentingunder intravascular ultrasound guidance.
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Figure 1: (A, B): Coronary angiogram showing tight in stent re-stenosis (ISR)in Left Anterior Descending (LAD) stent, followed by coronary arteryaneurysm in the prior stent. (C, D) Angiogram after stenting of prior mid LeftAnterior Descending (LAD) stent and coronary aneurysm. Post PCI TIMI IIIflow was achieved in LAD.
0.014 inch wire. Mid-LAD ISR was predilated withSaphire II (OrbusneichTM) 2.0x10 mm at 6 atm (Figures1C and 1D). Intravascular ultrasound (IVUS) revealedISR in proximal part of mid-LAD stent with aneurysm(Figure 2A). Xience xpedition (Abbott®) 2.5x33 mm(DES) was deployed into mid-LAD stent includingproximal and distal segments to it at 10 atm. Stent waspost-dilated sequentially with NC TREK (Abbott®)2.5x15 mm at 14-20 atm and NC TREK (Abbott®) 3.0x8mm at 10-16 atm. At the end of procedure, IVUSrevealed well-deployed and apposed stent with minimalgap in between two stent struts (Figure 2B). TIMI-III flowwas achieved in LAD.
The patient was kept on dual antiplatelets (DAPT) andglycoprotein IIb/IIIa inhibitor (GpIIb/IIIa) infusion. Sheimproved over the course of admission.
DISCUSSION
DES are impregnated with drugs which interfere withinflammatory pathways and neo-intimal proliferation,however, these local effects induce delayed re-endothelialisation, hypersensitivity reactions, andinflammatory changes of vessel wall, leading to CANformation.6,7 Coronary angiography is gold standardfor diagnosing CAN, yet it only gives informationregarding lumen of the arteries.2 IVUS allows detailedcharacterisation of the aneurysms, as it visualises layersof the coronary arteries and differentiates between trueand pseudo-aneurysms.8 Aoki et al. have classified CANinto 3 types.2 Type-1 occurs within 1 month secondary tomechanical injury to the arterial wall. Type-2 occurs after6 months of stent placement as an arterial wall responseto DES. Type-3 are infectious mycotic aneurysms.
There are no documented guidelines for management ofstent-related CAN. The only available data are isolatedmanagement protocols from individual case reports.These include observation, antiplatelet treatment, coilingor surgical excision.9 Aoki et al proposed a managementplan.2 They suggest percutaneous treatment with stent
graft, bavemetel stent (BMS) or surgery for large (morethan 2 times the size of reference vessel) or symptomaticpseudo-aneurysms and large and/or symptomatic trueaneurysms. For small or asymptomatic true andpseudoaneurysms, followup angiography at 3 to 6months is suggested. For small true aneurysms andthose large asymptomatic with no change in follow-upangiography, careful observation and DAPT issuggested. We used IVUS, as it aptly detects mal-apposition of DES and vessel wall and also defines thesize of aneurysms especially in cases of DESthrombosis.10 There is a lack of guidelines on the choiceof antiplatelet therapy and duration of antiplatelets incases of CAN. We decided to keep our patient post-PCIon DAPT and GpIIb/IIIa infusion for optimal antiplateleteffect.
CANs are rare vascular complications of DES. Theiroptimum treatment is still debatable, yet the applicationof DES under IVUS guidance can result in successfultreatment.
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Figure 2: (A) Intravascular ultrasound (IVUS) showing ISR along withaneurysm in prior mid Left Anterior Descending (LAD) stent. (B) Welldeployed and apposed stent with minimal gap in between two stent strutsvisualised.
